Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect(®) MDS/AML Disease Registry

Diagnostic and molecular genetic testing are key in advancing the treatment of acute myeloid leukemia (AML), yet little is known about testing patterns outside of clinical trials, especially in older patients. We analyzed diagnostic and molecular testing patterns over time in 565 patients aged ≥ 55...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollyea, Daniel A., George, Tracy I., Abedi, Mehrdad, Bejar, Rafael, Cogle, Christopher R., Foucar, Kathryn, Garcia‐Manero, Guillermo, Grinblatt, David L., Komrokji, Rami S., Maciejewski, Jaroslaw P., Revicki, Dennis A., Roboz, Gail J., Savona, Michael R., Scott, Bart L., Sekeres, Mikkael A., Thompson, Michael A., Kurtin, Sandra E., Louis, Chrystal U., Nifenecker, Melissa, Flick, E. Dawn, Swern, Arlene S., Kiselev, Pavel, Steensma, David P., Erba, Harry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Haematologic Malignancy ‐ Myeloid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176048/
https://www.ncbi.nlm.nih.gov/pubmed/35847712
http://dx.doi.org/10.1002/jha2.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176048/
https://www.ncbi.nlm.nih.gov/pubmed/35847712
http://dx.doi.org/10.1002/jha2.16

Ejemplares similares